|
OALib Journal期刊
ISSN: 2333-9721
费用：99美元
|
|
|
|
HLA class I-restricted MYD88 L265P-derived peptides as specific targets for lymphoma immunotherapy
DOI: 10.1080/2162402X.2016.1219825
Alexander N. R. Weber, Alice F. Muggen, Annika Nelde, Anton W. Langerak, Daniel Johannes Kowalewski, Falko Fend, Hans-Georg Rammensee, Heiko Schuster, Helmut Rainer Salih, Irina Bonzheim, Janet Kerstin Peper, Juliane Sarah Walz, Lothar Kanz, Olaf-Oliver Wolz, Rainer Claus, Stefan Stevanovi？, Yamel Cardona Gloria
Keywords: Cancer vaccine, HLA ligandome, immunotherapy, MyD88 L265P, neoantigen, non-Hodgkin lymphoma, peptide vaccination
Abstract:
Full-Text
|
|
Contact Us
service@oalib.com QQ:3279437679 
WhatsApp +8615387084133
|
|
